Acquirer · Corporate
Dechra
1Undisclosed—0
Image: Dechra (press release)Dechra buys Gallant to add off-the-shelf stem-cell therapies for pets
The EQT-owned veterinary drugmaker closed the deal a week after agreeing it, taking on a San Diego biotech whose first product is expected as early as 2027.
Undisclosedn/aSeries BCorporate
Latest in Dechra
All Dechra exitsOpen tracker →
Dechra → GallantUndisclosedUndisclosed